Portal vein embolization and application of autologous stem cells in patients with primary unresectable liver tumours

Abstrakt

Combination of PVE with HSC administration appeared to be a promising method that stimulated growth of FLRV with a subsequent possibility of an early radical liver resection. The issue is a danger of tumour progression in the liver parenchyma following the PVE with HSC.

The current randomized study should answer these questions.

Klíčová slova

• unresectable liver tumours
• portal vein embolization
• haematopoietic stem cells